Skip to main content

Table 4 Correlation between TSQM and 6MWD, medication administration time, and adverse events

From: Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension

 

Change in 6-minute walk distance*

Percent change in medication administration time*

Severity-weighted adverse event score †

TSQM

  Effectiveness

0.43 (p = 0.0004)

0.04 (p = 0.79)

−0.45 (p = 0.0002)

  Side effects

0.18 (p = 0.15)

0.18 (p = 0.17)

−0.44 (p = 0.0002)

  Convenience

0.24 (p = 0.06)

0.14 (p = 0.28)

−0.36 (p = 0.003)

  Global satisfaction

0.29 (p = 0.02)

0.14 (p = 0.30)

−0.35 (p = 0.005)

  1. * Compared to change in TSQM from Baseline to Week 12.
  2. † Compared to TSQM at Week 12.
  3. Medication administration time missing data for 5 subjects.
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us